Skip to main content
Top

Cardiovascular Drugs and Therapy

Issue 2/2021

Content (20 Articles)

Open Access SARS-CoV-2 Review Article

Thrombotic Complications in Patients with COVID-19: Pathophysiological Mechanisms, Diagnosis, and Treatment

Aleksandra Gąsecka, Josip A. Borovac, Rui Azevedo Guerreiro, Michela Giustozzi, William Parker, Daniel Caldeira, Gemma Chiva-Blanch

Open Access SARS-CoV-2 Review Article

Promising Therapy for Heart Failure in Patients with Severe COVID-19: Calming the Cytokine Storm

Xiang Peng, Yani Wang, Xiangwen Xi, Ying Jia, Jiangtian Tian, Bo Yu, Jinwei Tian

Myocarditis Review Article

Cardiovascular Complications of COVID-19: Pharmacotherapy Perspective

Azita Hajhossein Talasaz, Hessam Kakavand, Benjamin Van Tassell, Maryam Aghakouchakzadeh, Parham Sadeghipour, Steven Dunn, Babak Geraiely

Obesity Original Article

Comparative Effectiveness and Safety of Direct Oral Anticoagulants in Obese Patients with Atrial Fibrillation

Alexandros Briasoulis, Amgad Mentias, Alexander Mazur, Paulino Alvarez, Enrique C. Leira, Mary S. Vaughan Sarrazin

Stroke Original Article

Effect of Rivaroxaban or Apixaban in Atrial Fibrillation Patients with Stage 4–5 Chronic Kidney Disease or on Dialysis

Chen Chen, Yalin Cao, Ying Zheng, Yugang Dong, Jianyong Ma, Wengen Zhu, Chen Liu

Sinus Arrest Original Article

Vernakalant for Rapid Cardioversion of Recent-Onset Atrial Fibrillation: Results from the SPECTRUM Study

Samuel Lévy, Juha Hartikainen, Beate Ritz, Tord Juhlin, José Carbajosa-Dalmau, Hans Domanovits

Atrial Fibrillation Review Article

Pharmacologic Cardioversion in Patients with Paroxysmal Atrial Fibrillation: A Network Meta-Analysis

Dimitris Tsiachris, Ioannis Doundoulakis, Eirini Pagkalidou, Athanasios Kordalis, Spyridon Deftereos, Konstantinos A. Gatzoulis, Konstantinos Tsioufis, Christodoulos Stefanadis

Myocardial Infarction Original Article

One-Year COMBO Stent Outcomes in Acute Coronary Syndrome: from the COMBO Collaboration

Jaya Chandrasekhar, Vera C. de Winter, Deborah N. Kalkman, Samantha Sartori, Rishi Chandiramani, Melissa B. Aquino, Puk de Wilde, Doreen Zeebregts, Pier Woudstra, Marcel A. Beijk, Petr Hájek, Borislav Atzev, Martin Hudec, Tiong Kiam Ong, Martin Mates, Borislav Borisov, Hazem M. Warda, Peter den Heijer, Jaroslaw Wojcik, Andres Iniguez, Zdeněk Coufal, Michael Lee, Jan G. Tijssen, Karel T. Koch, Usman Baber, George D. Dangas, Antonio Colombo, Robbert J. de Winter, Roxana Mehran

Myocardial Infarction Original Article

Overlapping Drug-Eluting Stent Is Associated with Increased Definite Stent Thrombosis and Revascularization: Results from 15,561 Patients in the AUTHENTIC Study

Xiang Chen, Xiaofei Gao, Jing Kan, Rajiv Shrestha, Leng Han, Shu Lu, Xuesong Qian, Bill D. Gogas, Junjie Zhang, Shao-Liang Chen

Myocardial Infarction Original Article

Impact of PRECISE-DAPT and DAPT Scores on Dual Antiplatelet Therapy Duration After 2nd Generation Drug-Eluting Stent Implantation

Ji-Yong Jang, Hae Won Jung, Byoung-Kwon Lee, Dong-Ho Shin, Jung-Sun Kim, Sung-Jin Hong, Chul-Min Ahn, Byeong-Keuk Kim, Young-Guk Ko, Donghoon Choi, Myeong-Ki Hong, Kyung Woo Park, Hyeon-Cheol Gwon, Hyo-Soo Kim, Hyuck Moon Kwon, Yangsoo Jang

Open Access Original Article

Matrix Metalloproteinases Repress Hypertrophic Growth in Cardiac Myocytes

Gerhild Euler, Fabian Locquet, Joanna Kociszewska, Yvonne Osygus, Jacqueline Heger, Rolf Schreckenberg, Klaus-Dieter Schlüter, Éva Kenyeres, Tamara Szabados, Péter Bencsik, Péter Ferdinandy, Rainer Schulz

Atorvastatin Original Article

Dietary Cholesterol Exacerbates Statin-Induced Hepatic Toxicity in Syrian Golden Hamsters and in Patients in an Observational Cohort Study

Qiongyang Yu, Xiurui Ma, Yunan Wang, Haozhe Shi, Jian An, Yuhui Wang, Zhen Dong, Yijing Lu, Junbo Ge, George Liu, Xunde Xian, Aijun Sun

Chronic Kidney Disease Original Article

Maxacalcitol (22-Oxacalcitriol (OCT)) Retards Progression of Left Ventricular Hypertrophy with Renal Dysfunction Through Inhibition of Calcineurin-NFAT Activity

Kazunori Inoue, Isao Matsui, Takayuki Hamano, Keiji Okuda, Yasumasa Tsukamoto, Ayumi Matsumoto, Karin Shimada, Seiichi Yasuda, Yusuke Katsuma, Yoshitsugu Takabatake, Masaru Tanaka, Noriko Tanaka, Toshiaki Mano, Tetsuo Minamino, Yasushi Sakata, Yoshitaka Isaka

Heart Failure Correction

Correction to: Factor Xa Inhibition with Apixaban Does Not Influence Cardiac Remodelling in Rats with Heart Failure After Myocardial Infarction

Salva R. Yurista, Herman H. W. Silljé, Kirsten T. Nijholt, Martin M. Dokter, Dirk J. van Veldhuisen, Rudolf A. de Boer, B. Daan Westenbrink